In 2024, Modern Retina covered news from around the globe on clinical trials, technology in retina, trending topics in ...

EyeDNA Therapeutics’ HORA-PDE6b gets US FDA rare pediatric disease designation for patients with retinal dystrophy due to PDE6b gene mutations: Paris, France Friday, December 20 ...

Diabetic retinopathy is a progressive eye disease which results in vision impairment and ... Leber congenital amaurosis (LCA) and retinitis pigmentosa. The company's most advanced gene therapy program ...

Agreement Reached on Primary Endpoint and Phase 3 Trial DesignOral APX3330 is a Late-Stage Clinical Asset Available for PartneringFARMINGTON ...

The company is advancing its Phase I/II trial and exploring accelerated approval pathways in the US and Europe.

Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness.

Retinitis pigmentosa is a progressive, inherited eye disease causing retinal degeneration and vision loss, affecting approximately 2 million people globally. The research team aims to map the retina's ...

This project uses MobileNetV2 to detect Diabetic Retinopathy (DR) and classify its severity. It supports binary (DR vs. No DR) and multiclass (Mild, Moderate, Proliferative_DR, Severe) classifications ...

Narayana Nethralaya and SHG Technologies collaborate to develop 'Aura Vision' wearable device for low vision individuals in ...

Protect your vision as you age. Learn how diet, antioxidants, and lifestyle changes can prevent common eye conditions.

Retinitis pigmentosa (RP) is a progressive disease with four known stages that affects the ... Collectively, we’ll have a ...